Literature DB >> 20941759

Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.

Britta Bonn1, Carina Leandersson, Fabien Fontaine, Ismael Zamora.   

Abstract

The identification of metabolites is almost exclusively done with liquid chromatography/tandem mass spectrometry (LC/MSMS) and despite the enormous progress in the development of these techniques and software for handling of data this is a time-consuming task. In this study the use of quadrupole time-of-flight (QTOF)-generated MS(E) and MS/MS data were compared with respect to rationalization of metabolites. In addition Mass-MetaSite, a semi-automated software for metabolite identification, was evaluated. The program combines the information from MS raw data, in the form of collision-induced dissociation spectra, with a prediction of the site of metabolism in order to assign the structure of a metabolite. The aim of the software is to mimic the rationalization of fragment ions performed by a biotransformation scientist in the process of structural elucidation. For this evaluation, metabolite identification in human liver microsomes was accomplished for 19 commercially available compounds and 15 in-house compounds. The results were very encouraging and for 96% of the metabolites the same structures were assigned using MS(E) compared with MSMS acquired data. The possibility of using MS(E) could considerably reduce the analysis time. Moreover, Mass-MetaSite performed well and the correct assigned structure, compared to manual inspection of the data, was picked in the first rank in ∼80% of the cases. In conclusion MS(E) could be successfully used for metabolite identification in order to reduce time of analysis and Mass-MetaSite could alleviate the work of a biotransformation scientist and decrease the workload by assigning the structure for a majority of the metabolites.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941759     DOI: 10.1002/rcm.4753

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  11 in total

1.  Automatic Compound Annotation from Mass Spectrometry Data Using MAGMa.

Authors:  Lars Ridder; Justin J J van der Hooft; Stefan Verhoeven
Journal:  Mass Spectrom (Tokyo)       Date:  2014-07-02

2.  Shaping the future of safer innovative drugs in Europe.

Authors:  Jordi Mestres; Sharon D Bryant; Ismael Zamora; Johann Gasteiger
Journal:  Nat Biotechnol       Date:  2011-09-08       Impact factor: 54.908

Review 3.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

4.  Utilizing Microchip Capillary Electrophoresis Electrospray Ionization for Hydrogen Exchange Mass Spectrometry.

Authors:  William A Black; Bradley B Stocks; J Scott Mellors; John R Engen; J Michael Ramsey
Journal:  Anal Chem       Date:  2015-06-02       Impact factor: 6.986

Review 5.  Advances in the study of drug metabolism - symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX).

Authors:  Laura E Russell; Mary Alexandra Schleiff; Eric Gonzalez; Aaron G Bart; Fabio Broccatelli; Jessica H Hartman; W Griffith Humphreys; Volker M Lauschke; Iain Martin; Chukwunonso Nwabufo; Bhagwat Prasad; Emily E Scott; Matthew Segall; Ryan Takahashi; Mitchell E Taub; Jasleen K Sodhi
Journal:  Drug Metab Rev       Date:  2020-05-26       Impact factor: 4.518

6.  Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework.

Authors:  Russell S Thomas; Martin A Philbert; Scott S Auerbach; Barbara A Wetmore; Michael J Devito; Ila Cote; J Craig Rowlands; Maurice P Whelan; Sean M Hays; Melvin E Andersen; M E Bette Meek; Lawrence W Reiter; Jason C Lambert; Harvey J Clewell; Martin L Stephens; Q Jay Zhao; Scott C Wesselkamper; Lynn Flowers; Edward W Carney; Timothy P Pastoor; Dan D Petersen; Carole L Yauk; Andy Nong
Journal:  Toxicol Sci       Date:  2013-08-19       Impact factor: 4.849

7.  Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Authors:  Tatiana Radchenko; Andreas Brink; Yves Siegrist; Christopher Kochansky; Alison Bateman; Fabien Fontaine; Luca Morettoni; Ismael Zamora
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

8.  Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.

Authors:  Serena Massari; Chiara Bertagnin; Maria Chiara Pismataro; Anna Donnadio; Giulio Nannetti; Tommaso Felicetti; Stefano Di Bona; Maria Giulia Nizi; Leonardo Tensi; Giuseppe Manfroni; Maria Isabel Loza; Stefano Sabatini; Violetta Cecchetti; Jose Brea; Laura Goracci; Arianna Loregian; Oriana Tabarrini
Journal:  Eur J Med Chem       Date:  2020-10-16       Impact factor: 6.514

9.  Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.

Authors:  Tanya C Burch; Giorgis Isaac; Christiana L Booher; Johng S Rhim; Paul Rainville; James Langridge; Andrew Baker; Julius O Nyalwidhe
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.

Authors:  Laura Goracci; Jenny Desantis; Aurora Valeri; Beatrice Castellani; Michela Eleuteri; Gabriele Cruciani
Journal:  J Med Chem       Date:  2020-10-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.